Clinical Characteristics and Prognostic Analysis of Multiple Myeloma with Extramedullary Disease: A SEER-Based Study

Figure 4

The Kaplan–Meier estimate of myeloma-specific survival by subgroup analysis: (a) age; (b) gender; (c) race; (d) primary extramedullary sites; and (e) time interval from myeloma diagnosis to the occurrence of extramedullary disease.

(a)

(b)

(c)

(d)

(e)